What can we help you find?

Leading the way in transplantation

Filter results for:

Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)

Abstract Non-invasive biomarkers are promising tools for improving kidney allograft rejection monitoring, but their clinical adoption requires more evidence in specifically designed studies. To address this unmet need, we designed the EU-TRAIN study, a large prospective multicentric unselected cohort funded by the European Commission. Here, we included consecutive adult patients who received a kidney allograft

Maximise Your Impact with ESOT!

Improving transplant patient outcomes is at the forefront of our mission and, we are eager to collaborate with research teams who share the common goal of improving the lives of those hindered by inequitable access to life-changing treatments and procedures. Here’s why our involvement can be a game-changer for your project: Unmatched Expertise: With a

New resource available on Transplant Live: Management of CMV in solid organ transplant recipients

We are pleased to announce that our latest workshop, titled “Managing CMV in Solid Organ Transplant Recipients” is now available on ESOT Transplant Live [when in Transplant Live please go to Courses]. This educational programme aims to enhance the management of Cytomegalovirus (CMV) infections among transplant recipients, which can pose a significant challenge post-surgery. The

ESOT Masterclass Now Accepting Applications!

Aimed at young professional working in solid organ transplant, this Masterclass will provide crucial insight into the cutting-edge technologies that are about to revolutionise the transplantation field, including cell-free DNA, new plasma, urinary and immune function biomarkers, gene-expression profiling, as well as recent advances on HLA and non-HLA antibodies.